Concepedia

Vivek Srivastava

VS

Statistics

Publications

17

Citations

685

H-Index

15

Active since

2008

Affiliations

National Institute of Immunology(Current)

University of Oxford

John Radcliffe Hospital

Academy of Scientific and Innovative Research

United Arab Emirates University

Vivek Srivastava is an author at National Institute of Immunology specializing in life sciences, molecular biology, and medicine.

ORCID

Publications per year

2008–2024

17

Publications

17

Effects of canagliflozin on human myocardial redox signalling: clinical implications

Hidekazu Kondo, Ioannis Akoumianakis, Ileana Badi et al. · European Heart Journal · 2021 · 117 citations · Full text

, , +17

Telomere length-dependent transcription and epigenetic modifications in promoters remote from telomere ends

Ananda Kishore Mukherjee, Shalu Sharma, Suman Sengupta et al. · PLoS Genetics · 2018 · 81 citations · Full text

, , +17

Epigenetic suppression of human telomerase (hTERT) is mediated by the metastasis suppressor NME2 in a G-quadruplex–dependent fashion

Dhurjhoti Saha, Ankita Singh, Tabish Hussain et al. · Journal of Biological Chemistry · 2017 · 72 citations · Full text

, , +17

RECQL4 and p53 potentiate the activity of polymerase γ and maintain the integrity of the human mitochondrial genome

Shruti Gupta, Siddharth De, Vivek Srivastava et al. · Carcinogenesis · 2013 · 61 citations · Full text

, , +11

Molecular docking studies on DMDP derivatives as human DHFR inhibitors

Vivek Srivastava, Ashutosh Kumar, Bhartendu Nath Mishra et al. · Bioinformation · 2008 · 46 citations · Full text

, , +14

1–5 of 17